Primary lung cancer Metastatic lung tumor Benign lung tumor Infectious lung tumor Segmentectomy due to passive reasons
Conditions
Interventions
Indocyanine green 0.5 mg/kg is injected into a peripheral vein.
Sponsors
Yamaguchi University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients over 20 years old in obtaining written informed consent. 2. Indication of diseases A. cT1aN0M0, stage IA primary lung cancer with peripheral located, the diameter of 2 cm or smaller, and securing enough surgical margin at least the same diameter of the tumor size (same condition of JCOG0802/WJOG4607L) B. Metastatic lung tumor C. Benign tumor D. Infectious nodule E. segmentectomy due to passive reasons (e.g. insufficient pulmonary function) 3. Patients with obtaining written informed consent
Exclusion criteria
Exclusion criteria: 1. Patients with indocyanine green allergy 2. Patients with iodine allergy 3. Patients with liver cirrhosis (Child-Pugh grade B or worse) 4. Clinicians decide to exclude from this trial in some reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coincidence ratio of identification of segmental plan between infrared thoracoscopy with indocyanine green and inflation-deflation technique | — |
Secondary
| Measure | Time frame |
|---|---|
| Identification ratio of segmental plane using infrared thoracoscopy with indocyanine green in all cases Identification ratio of segmental plane using infrared thoracoscopy with indocyanine green in cases of failure of inflation-deflation technique Safety of using indocyanine green | — |
Countries
Japan
Contacts
Public ContactToshiki Tanaka
Yamaguchi University Hospital Department of Surgery and Clinical Science
Outcome results
None listed